iBio to Participate in Upcoming Healthcare Investor Conferences
iBio (NASDAQ: IBIO) announced participation in two upcoming healthcare investor conferences.
Rhea-AI Summary
iBio (NASDAQ: IBIO) announced participation in two upcoming healthcare investor conferences. CEO/CSO Martin Brenner and CFO Felipe Duran will present and hold investor meetings.
The events include the Jefferies Global Healthcare Conference on June 4, 2026, in New York and the Leerink Partners Therapeutics Forum on July 14–15, 2026, in Boston.
Positive
- None.
Negative
- None.
Details
News Market Reaction – IBIO
On Jun 3, the first trading day after this news, IBIO closed 4.55% above the previous close.
Data tracked by StockTitan Argus for the Jun 3 session.
Key Figures
- Jefferies presentation date
- June 4, 2026
- Jefferies Global Healthcare Conference presentation
- Jefferies presentation time
- 11:40 a.m. ET
- Scheduled presentation slot at Jefferies conference
- Webcast replay duration
- 90 days
- Replay availability on Investor Relations website
- Leerink forum dates
- July 14–15, 2026
- Leerink Partners Therapeutics Forum: I&I and Metabolism
Historical Context
-
Q3 FY2026 results plus obesity pipeline and cash runway update.
-
Addition of experienced biotech leader to board and committee.
-
Regulatory and ethics clearance for Phase 1 IBIO-600 trial.
-
Upcoming call on PH-HFpEF program and bispecific antibody plans.
-
IBIO-610 obese NHP data with fat reductions and long half-life.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO) (“iBio” or the “Company”), an AI-driven innovator developing therapies for cardiometabolic, obesity and cardiopulmonary diseases, today announced that Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer, and Felipe Duran, Chief Financial Officer, will participate in the Jefferies Global Healthcare Conference and the Leerink Partners Therapeutics Forum: I&I and Metabolism Conference.
Jefferies Global Healthcare Conference
Presentation Date: Thursday, June 4, 2026
Time: 11:40 a.m. ET
Location: Marriott Marquis, New York
A livestream of the event can be accessed link, and a replay of the presentation webcast will be available on the Investor Relations section of the iBio website for 90 days following the event.
Leerink Partners Therapeutics Forum: I&I and Metabolism
Event Dates: July 14–15, 2026
Location: Boston Harbor Hotel, Boston
Dr. Brenner and Mr. Duran will participate in one-on-one investor meetings during the Leerink conference. Preliminary meeting schedules are expected to be available in mid-June.
To request a meeting with Dr. Brenner or Mr. Duran at either conference, please contact ir@ibioinc.com.
About iBio, Inc.
iBio (Nasdaq: IBIO) is a clinical-stage biotechnology developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmonary diseases, cancer, and other hard-to-treat diseases. Combining advanced antibody engineering with AI-driven discovery, iBio is advancing a differentiated pipeline designed to deliver sustained therapeutic effects and address significant unmet medical needs. iBio’s mission is to transform drug discovery, accelerate development timelines, and unlock new possibilities in precision medicine. For more information, visit www.ibioinc.com or follow us on LinkedIn.
Contact:
iBio, Inc.
Investor Relations
ir@ibioinc.com
Ignacio Guerrero-Ros, Ph.D., or David Schull
Russo Partners, LLC
Ignacio.guerrero-ros@russopartnersllc.com
David.schull@russopartnersllc.com
(858) 717-2310 or (646) 942-5604
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.